Mergers & Acquisitions ·
Clarivate completes sale of Life Sciences and Healthcare business for $600M
CLVTClarivate PLC
Clarivate Plc completed the previously announced divestiture of its Life Sciences and Healthcare segment to an affiliate of Altaris, LLC. The transaction involves cash consideration of $500 million and an unsecured senior note with a principal amount of $75 million issued by the buyer, along with deferred consideration of $25 million payable upon completion of transition services or January 31, 2028. In connection with the closing, Henry Levy, Clarivate’s President for Life Sciences & Healthcare, terminated his employment under a separation agreement. The company intends to use proceeds to reduce debt and strengthen its balance sheet. Clarivate is a leading global provider of transformative intelligence solutions in academia, government, and intellectual property.